THOMAS A. LANE, M.D.; SANDOR S. SHAPIRO, M.D.; EDWARD R. BURKA, M.D., F.A.C.P.
A factor V inhibitor arose in a 79-year-old man within 1 month of an operation for a fractured leg. Absorption studies with solid-phase antibodies to human immunoglobulins showed the inhibitory activity to be primarily in the IgG class, but also in the IgA class, of immunoglobulins. This is the first report of an IgA immunoglobulin with factor V inhibitory activity. While the inhibitor was present, and at a time when no circulating Factor V activity was detectable, the patient developed septicemia and disseminated intravascular coagulation. The mechanism sustaining disseminated intravascular coagulation despite the absence of circulating factor V activity remains unexplained. The factor V inhibitor disappeared within 5 months of its initial detection. Possible origins of factor V inhibitors are discussed.
Learn more about subscription options.
Register Now for a free account.
LANE TA, SHAPIRO SS, BURKA ER. Factor V Antibody and Disseminated Intravascular Coagulation. Ann Intern Med. 1978;89:182-185. doi: 10.7326/0003-4819-89-2-182
Download citation file:
Published: Ann Intern Med. 1978;89(2):182-185.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only